Business Wire04.28.20
Masimo and MS Westfalia GmbH (MSW) announced that MSW will integrate additional Masimo measurement technologies into MSW’s plug-and-play hybrid Jenny platform, to help clinicians assess brain function, oxygenation, ventilation, and resuscitation status.
After launching the Jenny modular point-of-care monitoring device with integrated Masimo noninvasive, continuous rainbow SET measurements (including total hemoglobin, SpHb) and Masimo sidestream and mainstream NomoLine capnography, MSW plans to add Masimo Next Generation SedLine Brain Function Monitoring, O3 Regional Oximetry, and Oxygen Reserve Index (ORi) to Jenny. By doing so, MSW will make the platform an even more versatile and comprehensive monitoring solution, suitable for use in a variety of care areas, including the intensive care unit and the operating room, as well as in EMS and military settings.
The three additional technologies, currently available directly from Masimo on the Root Patient Monitoring and Connectivity Platform, are:
Eugen Kagan, CEO of MSW, said, “Our company’s mission is to save lives and improve quality of life for our patients. For more than 25 years, our goal has been to develop products that assist healthcare providers in the hospital and pre-hospital markets by helping to improve patient outcomes and increase patient satisfaction and workflow efficiency while lowering the cost of healthcare. We accomplish this by developing revolutionary approaches to new product development and by partnering with best-in-class partners like Masimo so we may meet the needs of a constantly changing healthcare landscape. The expanded technology partnership between MSW and Masimo allows us to offer our customers the most innovative technologies, helping them overcome many of the daily challenges they face in healthcare delivery.”
Joe Kiani, Founder and CEO of Masimo, said, “It’s great to see MSW’s commitment to incorporating our full suite of noninvasive, continuous measurements into their all-in-one modular Jenny platform. We are happy to be able to help MSW accomplish its mission.”
ORi has obtained CE marking and is not available in the United States.
After launching the Jenny modular point-of-care monitoring device with integrated Masimo noninvasive, continuous rainbow SET measurements (including total hemoglobin, SpHb) and Masimo sidestream and mainstream NomoLine capnography, MSW plans to add Masimo Next Generation SedLine Brain Function Monitoring, O3 Regional Oximetry, and Oxygen Reserve Index (ORi) to Jenny. By doing so, MSW will make the platform an even more versatile and comprehensive monitoring solution, suitable for use in a variety of care areas, including the intensive care unit and the operating room, as well as in EMS and military settings.
The three additional technologies, currently available directly from Masimo on the Root Patient Monitoring and Connectivity Platform, are:
- Next-Generation SedLine Brain Function Monitoring, which assists clinicians in monitoring the state of the brain under anesthesia, with bilateral data acquisition and processing of EEG signals and an enhanced Patient State Index (PSi).
- O3 Regional Oximetry, which may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain.
- ORi, the first noninvasive and continuous parameter to provide insight into the oxygen reserve of patients receiving supplemental oxygen.
Eugen Kagan, CEO of MSW, said, “Our company’s mission is to save lives and improve quality of life for our patients. For more than 25 years, our goal has been to develop products that assist healthcare providers in the hospital and pre-hospital markets by helping to improve patient outcomes and increase patient satisfaction and workflow efficiency while lowering the cost of healthcare. We accomplish this by developing revolutionary approaches to new product development and by partnering with best-in-class partners like Masimo so we may meet the needs of a constantly changing healthcare landscape. The expanded technology partnership between MSW and Masimo allows us to offer our customers the most innovative technologies, helping them overcome many of the daily challenges they face in healthcare delivery.”
Joe Kiani, Founder and CEO of Masimo, said, “It’s great to see MSW’s commitment to incorporating our full suite of noninvasive, continuous measurements into their all-in-one modular Jenny platform. We are happy to be able to help MSW accomplish its mission.”
ORi has obtained CE marking and is not available in the United States.
